Costs of the standard rheumatology care in active rheumatoid arthritis patients seen in a tertiary care center in Mexico City Blanca Hernández-Cruz, Rafael Ariza-Ariza, Mario H. Cardiel-Ríos

Cost evolution of biological drugs in rheumatoid arthritis patients in a tertiary hospital: Influential factors on price Mariángeles González Fernández, Elena Villamañán, Inmaculada Jiménez-Nácher, Francisco Moreno, Chamaida Plasencia, Francisco Gayá, Alicia Herrero, Alejandro Balsa

A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis Alberto Jiménez-Morales, Rafael Cáliz, Susana Aceituno, Miriam Prades, Carles Blanch